help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazennec, G.
Right arrow Articles by Wahli, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazennec, G.
Right arrow Articles by Wahli, W.
Molecular Endocrinology 14 (12): 1962-1975
Copyright © 2000 by The Endocrine Society

Activation of Peroxisome Proliferator-Activated Receptors (PPARs) by Their Ligands and Protein Kinase A Activators

Gwendal Lazennec, Laurence Canaple, Damien Saugy and Walter Wahli

INSERM U540 (G.L.) "Endocrinologie Moléculaire et Cellulaire des Cancers" 34090 Montpellier, France
Institut de Biologie Animale (G.L., L.C., D.S., W.W.) Université de Lausanne 1015 Lausanne, Switzerland

The nuclear peroxisome proliferator-activated receptors (PPARs) {alpha}, ß, and {gamma} activate the transcription of multiple genes involved in lipid metabolism. Several natural and synthetic ligands have been identified for each PPAR isotype but little is known about the phosphorylation state of these receptors. We show here that activators of protein kinase A (PKA) can enhance mouse PPAR activity in the absence and the presence of exogenous ligands in transient transfection experiments. Activation function 1 (AF-1) of PPARs was dispensable for transcriptional enhancement, whereas activation function 2 (AF-2) was required for this effect. We also show that several domains of PPAR can be phosphorylated by PKA in vitro. Moreover, gel retardation experiments suggest that PKA stabilizes binding of the liganded PPAR to DNA. PKA inhibitors decreased not only the kinase-dependent induction of PPARs but also their ligand-dependent induction, suggesting an interaction between both pathways that leads to maximal transcriptional induction by PPARs. Moreover, comparing PPAR{alpha} knockout (KO) with PPAR{alpha} WT mice, we show that the expression of the acyl CoA oxidase (ACO) gene can be regulated by PKA-activated PPAR{alpha} in liver. These data demonstrate that the PKA pathway is an important modulator of PPAR activity, and we propose a model associating this pathway in the control of fatty acid ß-oxidation under conditions of fasting, stress, and exercise.




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
S. Y. Park, H. K. Shin, J. H. Lee, C. D. Kim, W. S. Lee, B. Y. Rhim, and K. W. Hong
Cilostazol Ameliorates Metabolic Abnormalities with Suppression of Proinflammatory Markers in a db/db Mouse Model of Type 2 Diabetes via Activation of Peroxisome Proliferator-Activated Receptor {gamma} Transcription
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 571 - 579.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
Q. Gan, J. Huang, R. Zhou, J. Niu, X. Zhu, J. Wang, Z. Zhang, and T. Tong
PPAR{gamma} accelerates cellular senescence by inducing p16INK4{alpha} expression in human diploid fibroblasts
J. Cell Sci., July 1, 2008; 121(13): 2235 - 2245.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Coll, E. Eyre, R. Rodriguez-Calvo, X. Palomer, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera
Oleate Reverses Palmitate-induced Insulin Resistance and Inflammation in Skeletal Muscle Cells
J. Biol. Chem., April 25, 2008; 283(17): 11107 - 11116.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Gomberg-Maitland and H. Olschewski
Prostacyclin therapies for the treatment of pulmonary arterial hypertension
Eur. Respir. J., April 1, 2008; 31(4): 891 - 901.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Yamamoto, H. Shimano, N. Inoue, Y. Nakagawa, T. Matsuzaka, A. Takahashi, N. Yahagi, H. Sone, H. Suzuki, H. Toyoshima, et al.
Protein Kinase A Suppresses Sterol Regulatory Element-binding Protein-1C Expression via Phosphorylation of Liver X Receptor in the Liver
J. Biol. Chem., April 20, 2007; 282(16): 11687 - 11695.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Chen, X. Cheng, M. Z. Dieter, Y. Tanaka, and C. D. Klaassen
Activation of cAMP-Dependent Signaling Pathway Induces Mouse Organic Anion Transporting Polypeptide 2 Expression
Mol. Pharmacol., April 1, 2007; 71(4): 1159 - 1164.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Michalik, V. Zoete, G. Krey, A. Grosdidier, L. Gelman, P. Chodanowski, J. N. Feige, B. Desvergne, W. Wahli, and O. Michielin
Combined Simulation and Mutagenesis Analyses Reveal the Involvement of Key Residues for Peroxisome Proliferator-activated Receptor{alpha} Helix 12 Dynamic Behavior
J. Biol. Chem., March 30, 2007; 282(13): 9666 - 9677.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. Avallone, A. Demers, A. Rodrigue-Way, K. Bujold, D. Harb, S. Anghel, W. Wahli, S. Marleau, H. Ong, and A. Tremblay
A Growth Hormone-Releasing Peptide that Binds Scavenger Receptor CD36 and Ghrelin Receptor Up-Regulates Sterol Transporters and Cholesterol Efflux in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Pathway
Mol. Endocrinol., December 1, 2006; 20(12): 3165 - 3178.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
W. Li, T. Wang, C. Ma, T. Xiong, Y. Zhu, and X. Wang
Calcitonin gene-related peptide inhibits interleukin-1beta-induced endogenous monocyte chemoattractant protein-1 secretion in type II alveolar epithelial cells
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C456 - C465.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
A. Wagatsuma
Upregulation of gene encoding adipogenic transcriptional factors C/EBP{alpha} and PPAR{gamma}2 in denervated muscle
Exp Physiol, July 1, 2006; 91(4): 747 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. Paumelle, C. Blanquart, O. Briand, O. Barbier, C. Duhem, G. Woerly, F. Percevault, J.-C. Fruchart, D. Dombrowicz, C. Glineur, et al.
Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator-Activated Receptor-{alpha} via Inhibition of the Protein Kinase C Signaling Pathway
Circ. Res., February 17, 2006; 98(3): 361 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Li, Z. Zhu, Y. Lu, and J. G. Granneman
Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-{alpha}
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E617 - E626.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. M. Al-Rasheed, R. S. Chana, R. J. Baines, G. B. Willars, and N. J. Brunskill
Ligand-independent Activation of Peroxisome Proliferator-activated Receptor-{gamma} by Insulin and C-peptide in Kidney Proximal Tubular Cells: DEPENDENT ON PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY
J. Biol. Chem., November 26, 2004; 279(48): 49747 - 49754.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. Blanquart, R. Mansouri, R. Paumelle, J.-C. Fruchart, B. Staels, and C. Glineur
The Protein Kinase C Signaling Pathway Regulates a Molecular Switch between Transactivation and Transrepression Activity of the Peroxisome Proliferator-Activated Receptor {alpha}
Mol. Endocrinol., August 1, 2004; 18(8): 1906 - 1918.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Su, D. J. Mancuso, P. E. Bickel, C. M. Jenkins, and R. W. Gross
Small Interfering RNA Knockdown of Calcium-independent Phospholipases A2 {beta} or {gamma} Inhibits the Hormone-induced Differentiation of 3T3-L1 Preadipocytes
J. Biol. Chem., May 21, 2004; 279(21): 21740 - 21748.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
P. Froment, S. Fabre, J. Dupont, C. Pisselet, D. Chesneau, B. Staels, and P. Monget
Expression and Functional Role of Peroxisome Proliferator-Activated Receptor-{gamma} in Ovarian Folliculogenesis in the Sheep
Biol Reprod, November 1, 2003; 69(5): 1665 - 1674.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. A. Francis, J.-S. Annicotte, and J. Auwerx
PPAR-{alpha} effects on the heart and other vascular tissues
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H1 - H9.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. S. Welch, M. Ricote, T. E. Akiyama, F. J. Gonzalez, and C. K. Glass
PPAR{gamma} and PPAR{delta} negatively regulate specific subsets of lipopolysaccharide and IFN-{gamma} target genes in macrophages
PNAS, May 27, 2003; 100(11): 6712 - 6717.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Teruel, R. Hernandez, M. Benito, and M. Lorenzo
Rosiglitazone and Retinoic Acid Induce Uncoupling Protein-1 (UCP-1) in a p38 Mitogen-activated Protein Kinase-dependent Manner in Fetal Primary Brown Adipocytes
J. Biol. Chem., January 3, 2003; 278(1): 263 - 269.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Lim and S. K. Dey
Minireview: A Novel Pathway of Prostacyclin Signaling--Hanging Out with Nuclear Receptors
Endocrinology, September 1, 2002; 143(9): 3207 - 3210.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. M. Muoio, P. S. MacLean, D. B. Lang, S. Li, J. A. Houmard, J. M. Way, D. A. Winegar, J. C. Corton, G. L. Dohm, and W. E. Kraus
Fatty Acid Homeostasis and Induction of Lipid Regulatory Genes in Skeletal Muscles of Peroxisome Proliferator-activated Receptor (PPAR) alpha Knock-out Mice. EVIDENCE FOR COMPENSATORY REGULATION BY PPARdelta
J. Biol. Chem., July 12, 2002; 277(29): 26089 - 26097.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
P. D. Schoppee, J. C. Garmey, and J. D. Veldhuis
Putative Activation of the Peroxisome Proliferator-Activated Receptor {gamma} Impairs Androgen and Enhances Progesterone Biosynthesis in Primary Cultures of Porcine Theca Cells
Biol Reprod, January 1, 2002; 66(1): 190 - 198.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
D. P. Kelly
The Pleiotropic Nature of the Vascular PPAR Gene Regulatory Pathway
Circ. Res., November 23, 2001; 89(11): 935 - 937.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
D. A. Schreihofer, E. M. Resnick, V. Y. Lin, and M. A. Shupnik
Ligand-Independent Activation of Pituitary ER: Dependence on PKA-Stimulated Pathways
Endocrinology, August 1, 2001; 142(8): 3361 - 3368.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. C. Bendixen, N. K. Shevde, K. M. Dienger, T. M. Willson, C. D. Funk, and J. W. Pike
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1
PNAS, February 15, 2001; (2001) 41493198.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
W. Cao, A. V. Medvedev, K. W. Daniel, and S. Collins
beta -Adrenergic Activation of p38 MAP Kinase in Adipocytes. cAMP INDUCTION OF THE UNCOUPLING PROTEIN 1 (UCP1) GENE REQUIRES p38 MAP KINASE
J. Biol. Chem., July 13, 2001; 276(29): 27077 - 27082.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. C. Bendixen, N. K. Shevde, K. M. Dienger, T. M. Willson, C. D. Funk, and J. W. Pike
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1
PNAS, February 27, 2001; 98(5): 2443 - 2448.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society